Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4510.0
(0.0%)
JPY 4510.0
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | 4.11 Billion JPY | 4.44% |
| 2022 | 3.94 Billion JPY | 16.89% |
| 2021 | 3.37 Billion JPY | -3.46% |
| 2020 | 3.49 Billion JPY | -87.23% |
| 2019 | 27.36 Billion JPY | 2251.12% |
| 2018 | 1.16 Billion JPY | -75.33% |
| 2017 | 4.71 Billion JPY | 66.19% |
| 2016 | 2.83 Billion JPY | -19.51% |
| 2015 | 3.52 Billion JPY | 45.8% |
| 2014 | 2.41 Billion JPY | -27.83% |
| 2013 | 3.35 Billion JPY | 81.29% |
| 2012 | 1.84 Billion JPY | -29.18% |
| 2011 | 2.61 Billion JPY | 178.66% |
| 2010 | 937 Million JPY | -74.27% |
| 2009 | 3.64 Billion JPY | 4.78% |
| 2008 | 3.47 Billion JPY | 17.16% |
| 2007 | 2.96 Billion JPY | -2.01% |
| 2006 | 3.02 Billion JPY | -27.54% |
| 2005 | 4.17 Billion JPY | -27.86% |
| 2004 | 5.79 Billion JPY | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q3 | 1.3 Billion JPY | -2.9% |
| 2024 Q2 | 1.34 Billion JPY | 52.96% |
| 2024 Q1 | 878 Million JPY | -49.86% |
| 2023 Q3 | 1.28 Billion JPY | -6.7% |
| 2023 FY | 4.11 Billion JPY | 4.44% |
| 2023 Q4 | 1.75 Billion JPY | 36.58% |
| 2023 Q2 | 1.37 Billion JPY | 575.43% |
| 2023 Q1 | -289 Million JPY | -126.56% |
| 2022 Q3 | 1.01 Billion JPY | 4.98% |
| 2022 Q2 | 963 Million JPY | 9.18% |
| 2022 FY | 3.94 Billion JPY | 16.89% |
| 2022 Q1 | 882 Million JPY | -22.36% |
| 2022 Q4 | 1.08 Billion JPY | 7.62% |
| 2021 FY | 3.37 Billion JPY | -3.46% |
| 2021 Q4 | 1.13 Billion JPY | 14.29% |
| 2021 Q1 | 436 Million JPY | -55.83% |
| 2021 Q2 | 808 Million JPY | 85.32% |
| 2021 Q3 | 994 Million JPY | 23.02% |
| 2020 Q4 | 987 Million JPY | 39.41% |
| 2020 Q1 | 862 Million JPY | -4.33% |
| 2020 Q2 | 938 Million JPY | 8.82% |
| 2020 Q3 | 708 Million JPY | -24.52% |
| 2020 FY | 3.49 Billion JPY | -87.23% |
| 2019 Q3 | 272 Million JPY | 111.68% |
| 2019 Q4 | 901 Million JPY | 231.25% |
| 2019 FY | 27.36 Billion JPY | 2251.12% |
| 2019 Q1 | 28.52 Billion JPY | 2731.18% |
| 2019 Q2 | -2.32 Billion JPY | -108.16% |
| 2018 Q3 | 700 Million JPY | -28.5% |
| 2018 FY | 1.16 Billion JPY | -75.33% |
| 2018 Q1 | 569 Million JPY | -70.78% |
| 2018 Q4 | -1.08 Billion JPY | -254.86% |
| 2018 Q2 | 979 Million JPY | 72.06% |
| 2017 Q2 | 1.37 Billion JPY | 253.87% |
| 2017 FY | 4.71 Billion JPY | 66.19% |
| 2017 Q4 | 1.94 Billion JPY | 92.77% |
| 2017 Q3 | 1.01 Billion JPY | -26.44% |
| 2017 Q1 | 388 Million JPY | -64.21% |
| 2016 Q2 | 680 Million JPY | -15.32% |
| 2016 Q1 | 803 Million JPY | -32.86% |
| 2016 FY | 2.83 Billion JPY | -19.51% |
| 2016 Q4 | 1.08 Billion JPY | 298.53% |
| 2016 Q3 | 272 Million JPY | -60.0% |
| 2015 FY | 3.52 Billion JPY | 45.8% |
| 2015 Q4 | 1.19 Billion JPY | 71.1% |
| 2015 Q3 | 699 Million JPY | -36.45% |
| 2015 Q2 | 1.1 Billion JPY | 106.77% |
| 2015 Q1 | 532 Million JPY | 0.0% |
| 2014 Q3 | 806 Million JPY | 85.29% |
| 2014 Q1 | 974 Million JPY | 19.36% |
| 2014 FY | 2.41 Billion JPY | -27.83% |
| 2014 Q2 | 435 Million JPY | -55.34% |
| 2013 Q4 | 816 Million JPY | 9.24% |
| 2013 FY | 3.35 Billion JPY | 81.29% |
| 2013 Q1 | -43 Million JPY | -107.06% |
| 2013 Q2 | 815 Million JPY | 1995.35% |
| 2013 Q3 | 747 Million JPY | -8.34% |
| 2012 Q4 | 609 Million JPY | 2.01% |
| 2012 FY | 1.84 Billion JPY | -29.18% |
| 2012 Q1 | 132 Million JPY | -91.32% |
| 2012 Q2 | 686 Million JPY | 419.7% |
| 2012 Q3 | 597 Million JPY | -12.97% |
| 2011 FY | 2.61 Billion JPY | 178.66% |
| 2011 Q2 | 703 Million JPY | 136.71% |
| 2011 Q3 | 256 Million JPY | -63.58% |
| 2011 Q4 | 1.52 Billion JPY | 493.75% |
| 2011 Q1 | -1.91 Billion JPY | -273.46% |
| 2010 Q2 | 970 Million JPY | 199.38% |
| 2010 FY | 937 Million JPY | -74.27% |
| 2010 Q4 | 1.1 Billion JPY | 42.08% |
| 2010 Q3 | 777 Million JPY | -19.9% |
| 2010 Q1 | 324 Million JPY | -74.53% |
| 2009 Q1 | 163 Million JPY | -88.27% |
| 2009 Q2 | 997 Million JPY | 511.66% |
| 2009 Q3 | 1.04 Billion JPY | 5.12% |
| 2009 Q4 | 1.27 Billion JPY | 21.37% |
| 2009 FY | 3.64 Billion JPY | 4.78% |
| 2008 Q4 | 1.39 Billion JPY | 104.41% |
| 2008 Q3 | 680 Million JPY | 0.0% |
| 2008 FY | 3.47 Billion JPY | 17.16% |
| 2007 FY | 2.96 Billion JPY | -2.01% |
| 2006 FY | 3.02 Billion JPY | -27.54% |
| 2005 FY | 4.17 Billion JPY | -27.86% |
| 2004 FY | 5.79 Billion JPY | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 3.2 Billion JPY | -28.518% |
| Takeda Pharmaceutical Company Limited | 144.06 Billion JPY | 97.141% |
| Sumitomo Pharma Co., Ltd. | -314.96 Billion JPY | 101.308% |
| Shionogi & Co., Ltd. | 162.03 Billion JPY | 97.458% |
| Wakamoto Pharmaceutical Co.,Ltd. | 108.95 Million JPY | -3680.321% |
| Nippon Shinyaku Co., Ltd. | 25.85 Billion JPY | 84.066% |
| Kaken Pharmaceutical Co., Ltd. | 8.02 Billion JPY | 48.673% |
| Eisai Co., Ltd. | 42.4 Billion JPY | 90.287% |
| Morishita Jintan Co., Ltd. | 697 Million JPY | -490.961% |
| Hisamitsu Pharmaceutical Co., Inc. | 13.96 Billion JPY | 70.513% |
| Mochida Pharmaceutical Co., Ltd. | 4.54 Billion JPY | 9.413% |
| Fuso Pharmaceutical Industries,Ltd. | 1.37 Billion JPY | -199.129% |
| Nippon Chemiphar Co., Ltd. | -180 Million JPY | 2388.333% |
| Tsumura & Co. | 16.7 Billion JPY | 75.346% |
| Kissei Pharmaceutical Co., Ltd. | 11.16 Billion JPY | 63.091% |
| Towa Pharmaceutical Co., Ltd. | 16.17 Billion JPY | 74.532% |
| Fuji Pharma Co., Ltd. | 3.43 Billion JPY | -19.913% |
| Zeria Pharmaceutical Co., Ltd. | 7.73 Billion JPY | 46.723% |
| KYORIN Holdings, Inc. | 5.32 Billion JPY | 22.604% |
| Taiko Pharmaceutical Co.,Ltd. | -4.89 Billion JPY | 184.164% |
| Daito Pharmaceutical Co.,Ltd. | 3.29 Billion JPY | -25.008% |
| SymBio Pharmaceuticals Limited | -1.96 Billion JPY | 309.851% |
| MedRx Co., Ltd | -932 Million JPY | 541.953% |
| Mizuho Medy Co.,Ltd. | 3.77 Billion JPY | -9.135% |
| Solasia Pharma K.K. | -1.11 Billion JPY | 470.414% |
| Modalis Therapeutics Corporation | -2.39 Billion JPY | 272.212% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 7.54 Billion JPY | 45.408% |
| Sawai Group Holdings Co., Ltd. | 13.69 Billion JPY | 69.923% |
| Cyfuse Biomedical K.K. | -589.21 Million JPY | 799.07% |
| Toho Holdings Co., Ltd. | 20.65 Billion JPY | 80.06% |
| Koa Shoji Holdings Co.,Ltd. | 2.94 Billion JPY | -39.801% |